United States Securities and Exchange Commission · EDGAR Accession 0001488790-26-000005

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 1488790
Period 2025-12-31

Plasmology4, Inc.

CorporationNVIncorporated 2010Scottsdale, AZplasmology4.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 14%6 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(4,359,243)(6,999,368)▲ burn
Total assets12,483,429634,623
Cash & equivalents12,162,18916,676
Accounts receivable00
Short-term debt1,491,7581,492,220▼ 0%
Long-term debt276,1510
Taxes paid5627▲ 111%

Figures in USD as reported by the issuer.